Antiepileptic drug increases birth defect risk
Key points
- The results of a Finnish population-based study confirm that pregnant women taking the antiepileptic drug valproate run the risk of having a child with birth defects.
- "The offspring of women with epilepsy on valproate during the first trimester of pregnancy have a substantially increased risk for congenital malformations," said Dr.
- The risk for malformations is not elevated in offspring of mothers using other anti-seizure medications - carbamazepine, oxcarbazepine, or phenytoin - for epilepsy, Artama of the University of Tampere and colleagues report.
- To obtain "valid and precise estimates" of the risk of birth defects related to antiepileptic drug use during pregnancy, the team reviewed information on births occurring between 1991 and 2000 contained in the Finnish National Medical Birth Registry.
The results of a Finnish population-based study confirm that pregnant women taking the antiepileptic drug valproate run the risk of having a child with birth defects.
"The offspring of women with epilepsy on valproate during the first trimester of pregnancy have a substantially increased risk for congenital malformations," said Dr. Miia Artama, who led the study.
The risk for malformations is not elevated in offspring of mothers using other anti-seizure medications - carbamazepine, oxcarbazepine, or phenytoin - for epilepsy, Artama of the University of Tampere and colleagues report.
To obtain "valid and precise estimates" of the risk of birth defects related to antiepileptic drug use during pregnancy, the team reviewed information on births occurring between 1991 and 2000 contained in the Finnish National Medical Birth Registry.
They found that congenital malformations were significantly more common among offspring of women using antiepileptic medications (4.6 percent) than among offspring of women with epilepsy who went through pregnancy untreated (2.8 percent).
The likelihood of congenital malformations was 3 to 4 times higher for mothers who took valproate compared with untreated mothers, the investigators report in the medical journal Neurology. The use of valproate in doses greater than 1500 milligrams daily raised the risk tenfold.
In contrast, treatment with multiple antiepileptic drugs without valproate was not associated with increased risk of birth defects.
Summing up, Artama said the increased risk of malformations with different medications has to be weighed against their effectiveness for individual women.
SOURCE: Neurology, June 14, 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Pregnancy & Fertility →
NewsDrug-induced labor increases complication risk
Women who are given drugs to induce labor are nearly twice as likely to suffer an amniotic fluid embolism, a rare but potentially fatal complication of pregnancy, according to a study published on Friday. Researchers…
21 October 2006
NewsValproate linked to high birth defect rates
Roughly 20 percent of epileptic women who take the antiseizure drug valproate during pregnancy will have a fetus with a serious adverse outcome, almost twice the rate associated with the next most problematic…
8 August 2006
NewsScientists Find Genetic Cause of Multiple Birth Defects
The transition from fertilized egg to newborn baby requires an incredibly complex network of genes, proteins and biochemical signals that scientists are only beginning to understand. Most of the time, development…
9 May 2006
